BLACK WEEKSFlacons −15% · kits −10% · reste −5%avec le codeLivraison gratuite en Allemagne dès 200 €

Cette page a été traduite automatiquement et peut contenir des erreurs. Vous êtes de langue maternelle française ? Vos remarques et corrections sont les bienvenues.Envoyer un retour

The Peptide Desk The Peptide Desk
Klow Blend, photo du produit

Rapport de laboratoire

PDF
99%
Pureté
Testé
Klow Blend 80mg
Laboratoire
Analiza Białek
Date
August 2026
Résultat
99% purity (BPC-157 10.12 + TB-500 10.55 + GHK-Cu 61.85 + KPV 10.12 mg)
Endotoxines
6.29 EU/vial
N° de commande
Mot de passe

Testé de manière indépendante, vérifiable avec le mot de passe directement auprès du laboratoire.

Healing

Klow Blend

Healing

Commande

Prix unitaire - Livraison gratuite en Allemagne dès 200 € pendant les Black Weeks
  • DHL avec suivi
  • Emballage discret

4.6 sur 5 sur Trustpilot73 avis

En un coup d'œil

Klow Blend en chiffres

Les chiffres clés de notre lexique.

Article complet du lexique
Class
Healing/beauty blendextended
Use
Subcutaneousin mg
Sizes
80 mg1 size in the shop

Connaissances

Tout sur Klow Blend

Informations détaillées bientôt disponibles.

Bon à avoir

Ce dont vous avez besoin avec

L'eau bactériostatique est ajoutée automatiquement à votre panier. Seringues et tampons en un clic.

Seringues à insuline

10 pièces · 5.50 €

Tampons alcoolisés

50 pièces · 10 €

Combien d'eau ?

Unités sur la seringue pour la taille de votre flacon.

Ouvrir le calculateur →

FAQ

Questions fréquentes

Sources pour chaque réponse : article du lexique

Encore une question ?

Écrivez-nous, notre équipe vous aidera.

Are there studies on the Klow Blend?

No. As of 25 October 2026 there is no study on the ready-made blend, neither on ClinicalTrials.gov nor in PubMed. Only the single components have been studied, almost always each on its own. The only paper testing two components together (BPC-157 plus TB-500 in rats) found no added benefit of the combination.

What is in the Klow Blend?

Four peptides in one vial. BPC-157 comes from a protective protein in gastric juice, TB-500 is derived from thymosin beta-4, a protein that binds actin. GHK-Cu is a copper tripeptide found in the blood. KPV is a tripeptide from the hormone alpha-MSH. You also find all four individually in the lexicon.

Is the combination stronger than the single compounds?

That has not been studied. The idea behind the blend is that the pathways complement each other. In the only study with two components together (tendon healing in rats), BPC-157 plus TB-500 gave no advantage over either compound alone. The authors suspect that both act on shared pathways.

How well has BPC-157 been studied in humans?

Barely. A systematic review found 36 studies: 35 in animals or cells and one retrospective analysis of 12 people with knee pain. A second review from 2026 counted three small human studies with 30 people in total and rated the evidence as very low. Many animal studies come from a few research groups.

Is TB-500 the same as thymosin beta-4?

Not quite. TB-500 is described as a fragment of thymosin beta-4. Most studies, including the wound healing in rats and the phase 1 trial into a vein, used full thymosin beta-4. As eye drops thymosin beta-4 reached phase 3, which is a different use. The registry lists no trial on TB-500 itself.

What is known about GHK-Cu and KPV?

According to gene data GHK-Cu regulates at least 4,000 human genes and promotes collagen and elastin in cell studies. In humans it has mainly been studied as a cream in cosmetics. KPV reduced gut inflammation in mouse models, taken up via the transporter PepT1. There are no injection studies in humans for either.

Which side effects are known?

There are no data for the blend. The three small BPC-157 human studies reported no treatment-related side effects. Thymosin beta-4 was well tolerated in a phase 1 trial into a vein. Solid long-term data are missing for all four. Reviews also warn about contamination from unregulated manufacturing.

Is the Klow Blend approved?

No. Neither the blend nor any of the four components is approved as a medicine (as of October 2026). ChEMBL lists BPC-157 with phase 1 as the highest phase; thymosin beta-4 reached phase 3 only as eye drops.

Produits associés

Produits similaires